Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,420 | -9,138 | -19,431 | -12,301 | -130,553 |
| Depreciation Amortization | 338 | 457 | 220 | 2,343 | 3,182 |
| Income taxes - deferred | N/A | -2,281 | N/A | N/A | N/A |
| Accounts receivable | N/A | N/A | N/A | 7,971 | -7,352 |
| Accounts payable and accrued liabilities | -145 | -2,460 | -865 | -4,140 | 2,107 |
| Other Working Capital | -433 | -13,130 | 140 | -48,554 | 54,341 |
| Other Operating Activity | 336 | -15,174 | 1,535 | 8,723 | 41,215 |
| Operating Cash Flow | $-8,324 | $-41,726 | $-18,401 | $-45,958 | $-37,060 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 263 | 15,106 | N/A | 27,330 | -60,162 |
| PPE Investments | 2 | 137 | -1,339 | -245 | -1,902 |
| Net Acquisitions | N/A | 30,392 | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | -1,186 | -6,000 | 0 |
| Investing Cash Flow | $265 | $45,635 | $-2,525 | $21,085 | $-62,064 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 12,750 | N/A | N/A |
| Debt Repayment | N/A | -4,000 | N/A | -3,827 | -8,342 |
| Common Stock Issued | 7,659 | 114 | 54 | 426 | 130,037 |
| Other Financing Activity | -338 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $7,321 | $-3,886 | $12,804 | $-3,401 | $121,695 |
| Beginning Cash Position | 7,763 | 7,740 | 15,862 | 60,335 | 37,764 |
| End Cash Position | 7,025 | 7,763 | 7,740 | 32,061 | 60,335 |
| Net Cash Flow | $-738 | $23 | $-8,122 | $-28,274 | $22,571 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,324 | -41,726 | -18,401 | -45,958 | -37,060 |
| Capital Expenditure | -4 | -185 | -1,344 | -381 | -2,442 |
| Free Cash Flow | -8,328 | -41,911 | -19,745 | -46,339 | -39,502 |